Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD9567 vs Prednisolone Glucose Homeostasis in T2DM
NCT04556760Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mizacorat in Inflammatory Disorders, sponsored by AstraZeneca. Started Nov 2020; status: completed.
02
Drugs
mizacorat
03
Conditions
Inflammatory Disorders
Beyond the preview
Go deeper on NCT04556760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04556760.